ATACAND HCT is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Candesartan Cilexetil; Hydrochlorothiazide.
Product ID | 63629-3377_10548eb6-bfd4-4083-9bcf-6831ad0dd210 |
NDC | 63629-3377 |
Product Type | Human Prescription Drug |
Proprietary Name | ATACAND HCT |
Generic Name | Candesartan Cilexetil And Hydrochlorothiazide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2000-09-28 |
Marketing Category | NDA / NDA |
Application Number | NDA021093 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 32 mg/1; mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2007-02-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021093 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-23 |
Marketing Category | NDA |
Application Number | NDA021093 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-23 |
Marketing Category | NDA |
Application Number | NDA021093 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-23 |
Marketing Category | NDA |
Application Number | NDA021093 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-23 |
Ingredient | Strength |
---|---|
CANDESARTAN CILEXETIL | 32 mg/1 |
SPL SET ID: | 0ccca43b-b8d7-4310-b359-2e9dd4a681a9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0186-0162 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide |
0186-0322 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide |
0186-0324 | ATACAND HCT | Candesartan cilexetil Hydrochlorothiazide |
62559-650 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide |
62559-651 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide |
62559-652 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide |
63629-3377 | ATACAND HCT | ATACAND HCT |
0378-3001 | Candesartan Cilexetil and Hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
0378-3002 | Candesartan Cilexetil and Hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
0378-3003 | Candesartan Cilexetil and Hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
33342-131 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
33342-132 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
33342-133 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
43547-459 | candesartan cilexetil and hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
43547-460 | candesartan cilexetil and hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
43547-461 | candesartan cilexetil and hydrochlorothiazide | candesartan cilexetil and hydrochlorothiazide |
62559-660 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
62559-661 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
62559-662 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ATACAND HCT 75250934 2485478 Live/Registered |
ASTRAZENECA AB 1997-03-03 |